Best Traditional Pharmaceuticals Companies in California, United States
The 51 best Traditional Pharmaceuticals companies in California, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Ligand Pharmaceuticals.
Our analysis of 50 Traditional Pharmaceuticals companies
$3.2b in tracked funding; 51% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2016.
Ranked: Best Traditional Pharmaceuticals companies in California
| # | Company | Disclosed funding | Last round | Employees | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | Ligand Pharmaceuticals Manufacturer of drugs | $895M | 98 mo ago | 76 76 → 136 (+79%) | Todd Davis Chief Executive Officer & Director | — | — | — |
| 2 | GSMS Generic pharmaceutical supplier providing quality medications, unique packaging, and exceptional service | $470M | 85 mo ago | 79 | Benjamin Hall CEO & President | WordPressMySQLPHP+20 | — | — |
| 3 | Lykos Developer of therapeutics to treat mental health conditions | $315M | 31 mo ago | — | Amy Emerson CEO | WordPressApple iCloud MailMySQL+20 | — | — |
| 4 | Synthekine Developer of cytokine therapeutics | $290M | 42 mo ago | 104 | Debanjan Ray Chief Executive Officer | WordPressApple iCloud MailMicrosoft 365+28 | 290 patents Engineered IL‑10‑based cytokine fusion proteins for immunomodulatory therapeutics | — |
| 5 | Coherus Biosciences Developer of biosimilar therapeutics | $144M | 75 mo ago | 233 | — | DrupalApple iCloud MailMicrosoft 365+25 | 510 patents Antibody‑drug conjugates and ILT4‑targeted biologics for oncology therapy | — |
| 6 | SFJ Pharmaceuticals Specialty pharmaceutical company based on partnering model | $70M | 160 mo ago | 12 | — | WordPressMySQLPHP+28 | — | — |
| 7 | CORE Brand of energy drinks | $66M | 100 mo ago | 15 | — | WordPressMySQLPHP+18 | 20 patents Advanced printed circuit boards with integrated conductive/thermal constraining cores for high-performance electronics | — |
| 8 | Genexa Manufacturer of range of nutraceutical products | $60M | 41 mo ago | 23 23 → 40 (+74%) | David Johnson Chief Executive Officer | SanitySentryZendesk+44 | 14 patents Formulation of oral liquid and solid dosage forms for OTC cough and cold drugs | — |
| 9 | Dantari Developer of pharmaceutical products | $47M | 43 mo ago | 20 | Richard Markus CEO | — | 20 patents Patents concentrated in chemistry & materials | — |
| 10 | Nivagen Pharmaceuticals Developer and contract manufacturer of generic drugs, tablets, capsules, ointment and solution | $31M | 35 mo ago | 52 | Jay S. CEO & President | WordPressApple iCloud MailMicrosoft 365+21 | — | — |
| 11 | Genzum Life Sciences Provider of operation and maintenance services for industrial plants | $20M | 145 mo ago | 2 | Chris Achar Founder & Chief Executive Officer | — | — | — |
| 12 | Sonoma Pharmaceuticals Developer of pharma products for dermatological conditions | $20M | 101 mo ago | 45 | Matt H Founder | WordPressMySQLPHP+19 | — | — |
| 13 | Cipherome Manufacturer of drugs | $16M | 53 mo ago | 23 | Ju Han Kim Co-Founder | — | 35 patents Privacy-preserving federated machine learning for healthcare data and drug safety prediction. | — |
| 14 | LIVFRESH Dental Manufacturer of plaque removal toothpaste | $4M | 86 mo ago | — | Amit Goswamy Founder & CEO | Cart FunctionalityShopifySentry+46 | — | — |
| 15 | Petri Bio Manufacturer of microbe based drugs | $4M | 12 mo ago | 3 | Joseph Schinaman Co-Founder | — | — | — |
| 16 | sbmi.com Manufacturer of drugs | $4M | 200 mo ago | 11 | Edward Conk CEO | — | — | — |
| 17 | Elite Pharma Developer of controlled-release generic and branded pharmaceutical products | $3M | 72 mo ago | 53 | Nasrat Hakim CEO & President | WordPressMySQLPHP+21 | — | — |
| 18 | ABVC Manufacturer of plant based medicines and devices | $3M | 12 mo ago | 23 23 → 12 (-48%) | Uttam Patil Chief Executive Officer | WordPressMySQLPHP+17 | — | — |
| 19 | Absorption Pharmaceuticals Provider of consultancy services for sugar and alcohol processing | $2M | 150 mo ago | 11 | — | Cart FunctionalityShopifySentry+39 | — | — |
| 20 | Mimosa Therapeutics Manufacturer of psychedelic therapeutics | $865K | 61 mo ago | 5 | — | — | — | — |
| 21 | Innova Manufacturer of medical adhesives for wound care | $300K | — | — | Peter Friedman Co-Founder | — | — | — |
| 22 | Innovus Pharma Developer of science-backed dietary supplements for everyday wellness | $225K | 90 mo ago | 27 | — | — | — | — |
Top 12 Traditional Pharmaceuticals companies in California
#1
Funding Raised · Los Angeles, California · founded 2019 · 3 employees$3.5Mraised▾
Manufacturer of microbe based drugs
- Jul 2025Grant (prize money)$2.2M
- May 2022Grant (prize money)$1M
- Sep 2021Grant (prize money)$361.9K
#2
Public · Fremont, California · founded 1990 · 23 employees$2.7Mraised▾
Manufacturer of plant based medicines and devices
- Aug 2025Post IPO$2.5M
- Dec 2024Post IPO$200K
#3
Series A · San Jose, California · founded 2014$315.1Mraised▾
Developer of therapeutics to treat mental health conditions. The company uses a combination of MDMA (midomafetamine capsules), psychological intervention and other supportive services to treat post traumatic stress disorder.
- Jan 2024Series A$100M
- Sep 2023Series A$215.1M
#4
Series C · Menlo Park, California · founded 2018 · 104 employees$289.5Mraised▾
Developer of cytokine therapeutics
- Jan 2023Series C$100M
- Jun 2021Series B$107.5M
- Sep 2020Series A$82M
#5
Acquired · Sacramento, California · founded 2009 · 52 employees$31Mraised▾
Developer and contract manufacturer of generic drugs, tablets, capsules, ointment and solution
- Aug 2023Series B$5M
- Sep 2022Conventional Debt$45M
- May 2020Series B$16M
- Mar 2020Conventional Debt$8M
#6
Public · San Diego, California · founded 1987 · 76 employees$895Mraised▾
Manufacturer of drugs
- May 2018Post IPO$650M
- Aug 2014Post IPO$245M
- Oct 2001Post IPO—
#7
Series A · Beverly Hills, California · founded 2014 · 23 employees$60Mraised▾
Manufacturer of a range of nutraceutical products. The company provides products for sleep and stress, cold, flu, digestive health, and pain for adults as well as children. The products are supplied as sprays, drop liquids, and tablets. Their products are USDA Certified and non-GMO verified.
- Feb 2023Angel—
- Jul 2021Series A$60M
#8
Funding Raised · Camarillo, California · founded 1986 · 79 employees$470Mraised▾
Generic pharmaceutical supplier providing quality medications, unique packaging, and exceptional service. The company specializes in delivering high-quality, affordable generic pharmaceuticals and unique packaging solutions. Built on core values of innovation, integrity, quality, service, safety and dependability, the company is committed to improving health and the quality of care. They offer a wide portfolio of prescription products across a broad range of dosage forms, labeled in accordance with guidelines for standardization and consistency. They serve federal, state, county, and local governments, military pharmacies, and mail-order pharmacies. They focus on providing superior customer experience with every interaction and are dedicated to ensuring the integrity of the pharmaceutical supply chain.
- Jun 2019Conventional Debt$470M
#9
Series A · Thousand Oaks, California · founded 2018 · 20 employees$47Mraised▾
Developer of pharmaceutical products
- Dec 2022Series A$47M
#10
Public · Redwood City, California · founded 2010 · 233 employees$143.9Mraised▾
Developer of biosimilar therapeutics
- Apr 2020Post IPO$200M
- Jan 2019Conventional Debt$75M
- Dec 2017Post IPO$6.8M
- Feb 2016Post IPO$100M
#11
Acquired · Los Angeles, California · founded 2015 · 15 employees$65.5Mraised▾
CORE provides the pH balanced drink. It offers organic hydration with antioxidants and immunity increasing product. It is ultra purified and balanced with electrolytes and minerals.
- Apr 2018Series C$38.7M
- May 2016Series B$15.3M
- Apr 2015Series B$11.5M
#12
Late Stage · Pleasanton, California · founded 2008 · 12 employees$69.5Mraised▾
The SFJ Pharmaceuticals Group is a global Pharmaceutical company with a business model based on providing a financially advantageous and creative approach to drug development. SFJ’s partnering model pairs strategic funding and experienced clinical development resources with late phase drug development candidates across multiple indications. SFJ has successfully completed two clinical programs and is currently managing four global phase III oncology clinical trials across multiple therapeutic indications.
- Apr 2013PE$13M
- Oct 2012PE$500K
- Jul 2012PE$21M
- Apr 2012PE$35M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Traditional Pharmaceuticals coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Drug Discovery in California is moving
A read on the academic research around Drug Discovery in California — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 800 papers.
- University of California, San Francisco145
- University of California San Diego132
- University of California, Los Angeles92
- University of California, Davis65
- University of California, Berkeley63
- Computational biology19→97
- Chemical space3→36
- Small molecule7→30
- Virtual screening3→22
- Combinatorial chemistry2→20
- Computational biology12→47
- Docking (animal)7→21
- Bioinformatics1→13
- Pharmacology2→13
- Drug development1→10
- Chemical space1→6
- Drug repositioning1→4
- Virtual screening2→5
- Identification (biology)1→4
- Disease3→5